TORONTO, June 25, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, is pleased to announce that each of the Company and CannMart Inc. (“CannMart”), the Company’s wholly owned Ontario subsidiary, has entered into a services agreement (the “Services Agreement”) and a share purchase agreement (the “SPA ...

LifeStance Health Group (LFST) has been on a downward spiral lately with significant selling pressure. After declining 9% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier. Guide to Identifying Oversold Stocks We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting wheth ...

SCOTTSDALE, Ariz., May 23, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will participate in the following upcoming investor conferences. UBS Healthcare Services Cape Cod Summit Participants: Dave Bourdon, CFO, and Monica Prokocki, VP of Finance and Investor Relations Date: Tuesday, June 4, 2024 Location: Chatham Bars Inn, Chatham, MA Note: No presentation due to event format; inve ...

SCOTTSDALE, Ariz., May 23, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will participate in the following upcoming investor conferences. UBS Healthcare Services Cape Cod Summit Participants: Dave Bourdon, CFO, and Monica Prokocki, VP of Finance and Investor Relations Date: Tuesday, June 4, 2024 Location: Chatham Bars Inn, Chatham, MA Note: No presentation due to event format; inve ...

LifeStance Health (NASDAQ:LFST) stock is down on Wednesday after the mental health services company announced the pricing of a secondary offering for its shares. LifeStance Health says that a group of stockholders are selling shares of LFST stock in this public offering. This has them pricing the company’s shares at $6.25 each. They will sell a total of 20 million shares in the offering. In addition to this, the underwriters of the offering have a 30-day option to acquire another 3 million shares at this of ...

SCOTTSDALE, Ariz., May 21, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced the pricing of a secondary underwritten public offering of 20,000,000 shares of LifeStance’s common stock, par value $0.01 per share (the “Common Stock”) at a public offering price of $6.25 per share, pursuant to a shelf registration statement filed with the Securities an ...

SCOTTSDALE, Ariz., May 21, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced the pricing of a secondary underwritten public offering of 20,000,000 shares of LifeStance’s common stock, par value $0.01 per share (the “Common Stock”) at a public offering price of $6.25 per share, pursuant to a shelf registration statement filed with the Securities an ...

SCOTTSDALE, Ariz., May 21, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced that certain stockholders of the Company (the “Selling Stockholders”) intend to offer 20,000,000 shares of LifeStance’s common stock, par value $0.01 per share (the “Common Stock”), pursuant to a shelf registration statement filed with the Securities and Exchange Commissi ...

SCOTTSDALE, Ariz., May 21, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced that certain stockholders of the Company (the “Selling Stockholders”) intend to offer 20,000,000 shares of LifeStance’s common stock, par value $0.01 per share (the “Common Stock”), pursuant to a shelf registration statement filed with the Securities and Exchange Commissi ...

财务数据和关键指标变化 - 收入增长19%至3亿美元,调整后EBITDA增长174%至2800万美元 [7][29] - 访问量增长15%至190万次,人均收入增长4%至157美元 [29][30][33] - 中心利润率增长近4个百分点至31.5%,调整后EBITDA率增长5个百分点至9.2% [33][34][35] - 预计2024年全年收入保持在11.9亿至12.4亿美元,中心利润率和调整后EBITDA均有所提升 [39][40] 各条业务线数据和关键指标变化 - 公司未具体披露各业务线的数据和指标变化情况 [无] 各个市场数据和关键指标变化 - 公司未具体披露各市场的数据和指标变化情况 [无] 公司战略和发展方向及行业竞争 - 公司专注于提供高质量、可负担的心理健康服务,通过独特的门诊和网络内业务模式为患者和支付方提供更好的选择 [21][26][46] - 公司正在加强与支付方的谈判,要求获得适当的报酬,并取得一定成效,但也面临一个历史高于市场水平的支付方的报酬下调 [24][25][57][58] - 公司认为未来有进一步提高支付水平的空间,并计划在2025年实现两位数的利润率 [26][40] - 公司董事会新增一名精神病专科医生,以加强公司的医疗管理能力 [27] 管理层对经营环境和未来前景的评论 - 公司在过去6个季度连续实现或超越财务目标,体现了公司的韧性和可预测性 [7][18][19][43] - 公司的医生价值主张持续受到欢迎,医生数量有15%的有机增长 [8] - 公司的患者体验持续优秀,患者净推荐值为84,平均谷歌评分为4.5分 [8] - 公司对未来发展充满信心,将继续努力实现2024年正自由现金流和2025年两位数利润率的目标 [45] 问答环节重要的提问和回答 问题1 **Craig Hettenbach 提问** 询问公司的运营杠杆和实现10%利润率的路径 [49][50] **Ken Burdick 回答** 公司正处于2年的重建和加强基础的过程中,目前取得的进展只是初步成果,未来还有进一步提升效率和杠杆的空间 [50][51] 问题2 **Lisa Gill 提问** 询问公司与支付方的异常高报酬合同的情况 [55][56][57] **Ken Burdick 回答** 该合同是历史上的异常情况,现已调整至与其他支付方一致的水平,公司将继续努力争取更好的报酬 [57][58][59] 问题3 **Jack Senft 提问** 进一步询问上述异常高报酬合同的具体影响 [61][62][63] **Ken Burdick 回答** 公司不会过多披露具体的单一支付方谈判情况,但会在全年指引中反映该影响 [62][63][64]